Browsing ICR Divisions by subject "CA-125 Antigen"
Now showing items 1-1 of 1
Clinical factors of response in patients with advanced ovarian cancer participating in early phase clinical trials. (2017-05)Drug resistance to conventional anticancer therapies is almost inevitable in patients with advanced ovarian cancer (AOC), limiting their available treatment options. Novel phase I trial therapies within a dedicated drug ...